S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, Becker JC, Breitbart EW, Breuninger H, Diepgen T, Dirschka T, Eigentler T, El Gammal AK, Felcht M, Flaig MJ, Follmann M, Fritz K, Grabbe S, Greinert R, Gutzmer R, Hauschild A, Hillen U, Ihrler S, John SM, Kofler L, Koelbl O, Krause-Bergmann A, Kraywinkel K, Krohn S, Langer T, Loquai C, Löser CR, Mohr P, Nashan D, Nothacker MJ, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Voelter-Mahlknecht S, Vordermark D, Weichenthal M, Welzel J, Wermker K, Wiegand S, Garbe C, Berking C (2023)

Publication Language: English

Publication Type: Journal article

Publication year: 2023

Journal

Book Volume: 21

Pages Range: 1249-1262

Journal Issue: 10

DOI: 10.1111/ddg.15231

Abstract

Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma” was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to AK, actinic cheilitis, Bowen's disease, occupational disease and care structures.

Authors with CRIS profile

Involved external institutions

Eberhard Karls Universität Tübingen Germany (DE) Arbeitsgemeinschaft Dermatologische Prävention (ADP) e. V. Germany (DE) Universitätsklinikum Essen Germany (DE) Ruhr-Universität Bochum (RUB) Germany (DE) Technische Universität Dresden Germany (DE) Centroderm GmbH Germany (DE) Charité - Universitätsmedizin Berlin Germany (DE) Klinikum Gütersloh Germany (DE) Deutsche Krebsgesellschaft (DKG) Germany (DE) Vivantes - Netzwerk für Gesundheit GmbH Germany (DE) Robert Koch-Institut (RKI) Germany (DE) Deutsche Gesetzliche Unfallversicherung e.V. (DGUV) Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Dermpath München Germany (DE) Universität Osnabrück Germany (DE) Universitätsklinikum Tübingen Germany (DE) Universitätsklinikum Regensburg Germany (DE) Klinikum Dortmund Germany (DE) AWMF-Institut für Medizinisches Wissensmanagement (AWMF-IMWi) Germany (DE) Elbe Kliniken Stade-Buxtehude Germany (DE) Klinikum Osnabrück Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU) Germany (DE) Dermatologie am Regierungsviertel Germany (DE) Universitätsklinikum Augsburg Germany (DE) Carol Davila University of Medicine and Pharmacy / Universitatea de Medicină și Farmacie „Carol Davila” (UMF București) Romania (RO) Klinikum der Stadt Ludwigshafen am Rhein gGmbH Germany (DE) Klinikum Vest Germany (DE) Universitätsklinikum Leipzig Germany (DE) Klinikum Bremen-Ost Germany (DE) Hautärzte- und Laserzentrum Pfalz Germany (DE) St. Josefskrankenhaus Germany (DE) Johannes Gutenberg-Universität Mainz (JGU) Germany (DE) Ruprecht-Karls-Universität Heidelberg Germany (DE) Diakonie Hospital Bethesda Germany (DE) Ludwig-Maximilians-Universität (LMU) Germany (DE)

How to cite

APA:

Heppt, M., Leiter, U., Steeb, T., Alter, M., Amaral, T., Bauer, A.,... Berking, C. (2023). S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care. Journal der Deutschen Dermatologischen Gesellschaft, 21(10), 1249-1262. https://dx.doi.org/10.1111/ddg.15231

MLA:

Heppt, Markus, et al. "S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care." Journal der Deutschen Dermatologischen Gesellschaft 21.10 (2023): 1249-1262.

BibTeX: Download